Although 100% of both Adam29+/+ and Adam29−/− mice presented microvacuolar steatosis, the incidence of macrovacuolar steatosis and hepatocyte hypertrophy was reduced in Adam29−/− animals, whereas inflammation incidence was higher in these animals (Figure 2I). This evidence concerns the gene ADAM29 and steatosis.